Cart
sales@molnova.com
JAK-IN-5
CAS No. 2096999-92-5
JAK-IN-5( —— )
Catalog No. M26263 CAS No. 2096999-92-5
JAK-IN-5 is a JAK inhibitor (Compound 283 from patent US20170121327A1).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 567 | In Stock |
|
| 5MG | 391 | In Stock |
|
| 10MG | 582 | In Stock |
|
| 25MG | 928 | In Stock |
|
| 50MG | 1228 | In Stock |
|
| 100MG | 1655 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 3311 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameJAK-IN-5
-
NoteResearch use only, not for human use.
-
Brief DescriptionJAK-IN-5 is a JAK inhibitor (Compound 283 from patent US20170121327A1).
-
DescriptionJAK-IN-5 is a JAK inhibitor (Compound 283 from patent US20170121327A1).
-
In Vitro——
-
In VivoJAK-IN-5 (compound 1) (oral aspirate, 0.5 mg/mL, 50 μL ) inhibits STAT6 phosphorylation by 60% in IL-13-induced in lung tissue in a mouse model of pSTAT6 induction.JAK-IN-5 (compound 1) (oral aspirate, 0.1-1.0 mg/mL, 50 μL) inhibits 88% of BALF eosinophils in male C57 mice model of Alternaria alternata-induced eosinophilic inflammation of the lung.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetJAK
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2096999-92-5
-
Formula Weight474.584
-
Molecular FormulaC27H31FN6O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCc1cc(O)c(F)cc1-c1ccc2c(n[nH]c2c1)-c1nc2CN(CCc2[nH]1)C1CCN(C)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhao H, Liu Q et al. In vitro additive antitumor effects of dimethoxycurcumin and 5-fluorouracil in colon cancer cells. Cancer Med. 2017 Jul;6(7):1698-1706.
molnova catalog
related products
-
TG-101209
A potent, selective, orally bioavailable JAK2 inhibitor with IC50 of 6 nM; also inhibits FLT3 (IC50=25 nM) and RET (IC50=17 nM) kinases, weakly inhibits JAK3 (IC50=168 nM).
-
Atiprimod dihydrochl...
Atiprimod (SKF 106615, Azaspirane) is a potent, orally bioavailable JAK2 inhibitor, inhibits phosphorylation of JAK2 and the downstream STAT3 and STAT5 pathways.
-
Reticuline
Reticuline, isolated from Litsea cubeba, shows anti-inflammatory effects through JAK2/STAT3 and NF-κB signaling pathways.
